Found: 30
Select item for more details and to access through your institution.
Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.
- Published in:
- Journal of Pathology, 2016, v. 238, n. 4, p. 531, doi. 10.1002/path.4650
- By:
- Publication type:
- Article
Alendronate-Induced Ulcerative Esophagitis.
- Published in:
- 1996
- By:
- Publication type:
- Letter
Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2013, v. 33, n. 7, p. 1062, doi. 10.1111/liv.12165
- By:
- Publication type:
- Article
Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD—not everyone fits the mould. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 182, doi. 10.1111/apt.16972
- By:
- Publication type:
- Article
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 11, p. 1441, doi. 10.1111/apt.16874
- By:
- Publication type:
- Article
Nonalcoholic fatty liver disease in Women.
- Published in:
- Women's Health (17455057), 2009, v. 5, n. 2, p. 191, doi. 10.2217/17455057.5.2.191
- By:
- Publication type:
- Article
Increased production of sonic hedgehog by ballooned hepatocytes.
- Published in:
- Journal of Pathology, 2011, v. 224, n. 3, p. 401, doi. 10.1002/path.2888
- By:
- Publication type:
- Article
The role of glucagon‐like peptide‐1 receptor agonists in metabolic dysfunction‐associated steatohepatitis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2001, doi. 10.1111/dom.15524
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. i, doi. 10.1111/liv.14442
- By:
- Publication type:
- Article
Succinate‐GPR‐91 receptor signalling is responsible for nonalcoholic steatohepatitis‐associated fibrosis: Effects of DHA supplementation.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 830, doi. 10.1111/liv.14370
- By:
- Publication type:
- Article
Relationship between three commonly used non‐invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2019, v. 39, n. 5, p. 924, doi. 10.1111/liv.13974
- By:
- Publication type:
- Article
Tropheryma whippelii DNA is rare in the intestinal mucosa of patients without other evidence of Whipple disease.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis.
- Published in:
- FASEB Journal, 2013, v. 27, n. 4, p. 1674, doi. 10.1096/fj.12-219097
- By:
- Publication type:
- Article
Expression of mitochondrial membrane-linked SAB determines severity of sex-dependent acute liver injury.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 842, doi. 10.1002/ehf2.13250
- By:
- Publication type:
- Article
Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 14, p. 1, doi. 10.1161/JAHA.123.029873
- By:
- Publication type:
- Article
Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Validation of the accuracy of the FAST<sup>™</sup> score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0266859
- By:
- Publication type:
- Article
Nonalcoholic Fatty Liver Disease.
- Published in:
- North Carolina Medical Journal, 2016, v. 77, n. 3, p. 216, doi. 10.18043/ncm.77.3.216
- By:
- Publication type:
- Article
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47919-9
- By:
- Publication type:
- Article
Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0204308
- By:
- Publication type:
- Article
Successful Treatment of Chronic Hepatitis C With Pegylated Interferon, Ribavirin, and Infliximab in a Patient with Crohn's Disease.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Betaine, a Promising New Agent for Patients With Nonalcoholic Steatohepatitis: Results of a Pilot Study.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2001, v. 96, n. 9, p. 2711, doi. 10.1111/j.1572-0241.2001.04129.x
- By:
- Publication type:
- Article
1848-P: Insulin Sensitivity and Metabolic Profile of Subjects with Type 2 Diabetes and Nonalcoholic Steatohepatitis after Exposure to Cenicriviroc: A Subanalysis of the CENTAUR Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1848-P
- By:
- Publication type:
- Article
1839-P: Glycemic Control Impacts Severity of Hepatic Fibrosis in NAFLD/NASH.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1839-P
- By:
- Publication type:
- Article
136-OR: Efficacy of Cenicriviroc (CVC) in Adults with NASH-Induced Liver Fibrosis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-136-OR
- By:
- Publication type:
- Article
1164-P: Effects of Cenicriviroc in Adults with NASH on Inflammatory Cytokines and Metabolic Parameters.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1164-P
- By:
- Publication type:
- Article
1148-P: Cenicriviroc Safety in over 1,200 Subjects.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1148-P
- By:
- Publication type:
- Article
1876-P: Impact of Diabetes on Liver Disease Progression in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1876-P
- By:
- Publication type:
- Article